Stocks
Neurocrine Biosciences (NBIX) Net debt US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net debt, bln rub | -270.9 | -726.4 | -603.2 | -621.0 | -1 065 | -910.0 | |||
| Changes by years, y/y, % | -30% | +168% | -17% | +3% | +72% | +22.3% | |||
Neurocrine Biosciences. Net debt, bln rub
Neurocrine Biosciences. Net debt, changes, %
Neurocrine Biosciences (NBIX) Net debt US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Net debt, bln rub | -496.0 | -536.5 | -206.7 | -1 065 | -910.0 | -910.0 | ||
| Changes by years, y/y, % | -29% | -31% | -79% | +72% | +83% | |||
| Changes by quarters, q/q, % | -20% | +8% | -61% | +415% | -15% | |||
